Table of Contents

company-logo

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

MaxCyte Dividend Announcement

• MaxCyte does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on MaxCyte dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

MaxCyte Dividend History

MaxCyte Dividend Yield

MaxCyte current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing MaxCyte stock? Use our calculator to estimate your expected dividend yield:

MaxCyte Financial Ratios

P/E ratio-12.27
PEG ratio0.70
P/B ratio2.05
ROE-16.01%
Payout ratio0.00%
Current ratio9.81
Quick ratio9.22
Cash Ratio2.10

MaxCyte Dividend FAQ

Does MaxCyte stock pay dividends?
MaxCyte does not currently pay dividends to its shareholders.
Has MaxCyte ever paid a dividend?
No, MaxCyte has no a history of paying dividends to its shareholders. MaxCyte is not known for its dividend payments.
Why doesn't MaxCyte pay dividends?
There are several potential reasons why MaxCyte would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will MaxCyte ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While MaxCyte has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is MaxCyte a dividend aristocrat?
MaxCyte is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is MaxCyte a dividend king?
MaxCyte is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is MaxCyte a dividend stock?
No, MaxCyte is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy MaxCyte stocks?
To buy MaxCyte you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy MaxCyte stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.